On January 10, 2023, the "Second Gene Testing Industry Development Summit Forum" hosted by Southern Medical Lab Website, Gene Valley, Gene Technology Website, and Early Screening Website was held in Guangzhou. The results of the "2022 Gene Testing Industry Annual Selection " were officially released at the forum, aiming to recognize outstanding enterprises and individuals who have made great contributions to the gene testing industry in the past year, and encourage practitioners to not forget their original aspirations and forge ahead. This activity adheres to the principles of fairness, impartiality, and openness, and is conducted in the form of "judge selection + online voting". The ranking voting accounts for 50%, and the judge selection accounts for 50%. Since its launch, the event has received widespread attention and high recognition from the industry. Genetic testing companies from all over the country have enthusiastically applied, and people who are concerned about industry development have actively voted. According to statistics, a total of 650,000 valid votes were received in this event.

This selection activity focuses on three dimensions: technological innovation, market application, and capital ecology. Multiple industry rankings have been selected, vividly showcasing the latest developments in the industry. With leading technology in the field of cancer testing, Dunwill Medical has been awarded the "Gene Testing Industry Technology Innovation Award".

For many years, Dunwill Medical has been committed to be driven by clinical needs, and becoming a one-stop solution provider of multi-omics R&D platforms, covering genomics, cell phenomics, proteomics, bioinformatics, and Al etc. The honor of winning this selection is a recognition of Dunwill Medical's innovation and market application. In the future, Dunwill Medical will continue to maintain its scientific innovation and strive to fulfill its mission of powering the future of medicine.